Beyond Medical Technologies Inc.
DOCT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 70.30K | 83.70K | 88.00K | 108.10K | 73.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.30K | 83.70K | 88.00K | 108.10K | 73.80K |
| Operating Income | -70.30K | -83.70K | -88.00K | -108.10K | -73.80K |
| Income Before Tax | -73.60K | -42.50K | -47.90K | -110.90K | -76.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -73.60K | -42.50K | -47.90K | -110.90K | -76.40K |
| Earnings from Discontinued Operations | 100.00 | 58.20K | 100.00 | -77.00K | 1.70K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.50K | 15.70K | -47.80K | -187.90K | -74.80K |
| EBIT | -70.30K | -83.70K | -88.00K | -108.10K | -73.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.00 | -0.01 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 7.91M | 7.91M | 7.91M | 7.91M | 7.91M |
| Average Diluted Shares Outstanding | 7.91M | 7.91M | 7.91M | 7.91M | 7.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
